Soligenix (NASDAQ: SNGX) Highlights Patient-Centric Drug Development Strategy Through Reformulation Approach

By Christopher J. Schaber, chairman, president, and CEO, Soligenix; published via Clinical Leader Soligenix (NASDAQ: ...
Reason

OxyContin's Reformulation Linked to Rising Suicides by Children

In 2010, Purdue Pharma replaced the original version of OxyContin, an extended-release oxycodone pill, with a reformulated product that was much harder to crush for snorting or injection. The idea was ...
MedPage Today

Did Reformulated OxyContin Really Discourage Abuse?

An FDA advisory panel will vote later this week on whether or not Purdue Pharma's abuse-deterrent formulation (ADF) of oxycodone (OxyContin) "meaningfully reduced" opioid-related overdoses and deaths ...

Soligenix (SNGX) Highlights Patient-Centric Drug Development Strategy Through Reformulation Approach

Soligenix (NASDAQ: SNGX) is emphasizing the strategic importance of patient-centric drug development, as outlined by CEO ...